Cell Product Definition

  • Onkimmune is exploring both KHYG-1 and cord-derived NK cells as potential platforms for NK cellular therapy for cancer.
  • NK cells can be modified by adding a CAR that recognizes a specific cancer cell and helps homing and recognition of the cancer cell.
  • It is also possible to add modifications to the NK cells, +/-TRAIL variant, +/-modifications to switch off immune inhibitory mechanisms, and in combination with check point inhibitors in some cases

Product Pipeline

PRODUCT CLINICAL INDICATION IN VITRO ACTIVITY IN VITRO POP PRODUCT CANDIDATE PRE-CLINICAL SAFETY IND PHASE 1/2 CLINICAL PARTNERED
ONK 3010 AML ONKIMMUNE
ONK 3020 AML IN DISCUSSIONS
ONK 1000 MM ONKIMMUNE
ONK S6600 BREAST ONKIMMUNE
ONK S7000 OVARIAN ONKIMMUNE